Daniël de Bruyn

Daniël de Bruyn is a Researcher in the Department of Ophthalmology at Erasmus University Medical Center (Erasmus MC) in Rotterdam, Netherlands. His primary focus is on uveal melanoma research, with particular expertise in molecular diagnostics and liquid biopsy techniques.

Dr. de Bruyn's research interests span several key areas in ocular oncology and molecular diagnostics:

• Uveal melanoma molecular classification and subtyping
• Circulating tumor DNA as a liquid biomarker for cancer detection
• Metabolomics and metabolic phenotyping in ocular cancers
• Biomarker discovery for prognosis and treatment monitoring
• Application of artificial intelligence in histopathological analysis

His recent publications (2022-2024) demonstrate a strong focus on developing non-invasive diagnostic and monitoring approaches for uveal melanoma, particularly through the analysis of circulating tumor DNA and metabolic profiles. His work bridges the gap between laboratory research and clinical application, aiming to improve early detection of metastasis and personalized treatment approaches for patients with ocular cancers.

Dr. de Bruyn actively collaborates with researchers across multiple institutions, as evidenced by his co-authorship on studies involving international teams including the Rotterdam Ocular Melanoma Study Group (ROMS). His publications have received citations across various platforms, indicating growing recognition in the field of ocular oncology.